Eskay Herbal Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.76 Cr
as on 11-12-2024
- Revenue 7.51%
(FY 2021)
- Profit 11.27%
(FY 2021)
- Ebitda 21.06%
(FY 2021)
- Net Worth 75.99%
(FY 2021)
- Total Assets 90.48%
(FY 2021)
About Eskay Herbal Formulations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.76 Cr.
Nikunj Agrawal and Dhiraj Agrawal serve as directors at the Company.
- CIN/LLPIN
U85191MH2008PTC186746
- Company No.
186746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Eskay Herbal Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhiraj Agrawal  | Managing Director | 15-Sep-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikunj Agrawal | Whole-Time Director | 15-Sep-2008 | Current |
Financial Performance of Eskay Herbal Formulations.
Eskay Herbal Formulations Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 7.51% increase. The company also saw a substantial improvement in profitability, with a 11.27% increase in profit. The company's net worth Soared by an impressive increase of 75.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eskay Herbal Formulations?
In 2021, Eskay Herbal Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maharashtra Biofuels Private LimitedActive 9 months 3 daysNikunj Agrawal and Dhiraj Agrawal are mutual person
- S.K. Greentex Private LimitedActive 13 years 4 months
Nikunj Agrawal and Dhiraj Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Aug 2012 | ₹8.76 Cr | Open |
How Many Employees Work at Eskay Herbal Formulations?
Unlock and access historical data on people associated with Eskay Herbal Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eskay Herbal Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eskay Herbal Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
